Nature's Capital: Why Asia's Governments Are Turning to Nature-Based Solutions
SINGAPORE, March 17, 2026 /PRNewswire/ -- Lester Chan, CEO & Chairman, The GrowHub Limited (Nasdaq: TGHL) explains h ow forests, mangroves, and peatlands are reshaping climate strategy The first wave of carbon markets was about avoidance. The...
NATURE'S MIRACLE HOLDING INC. PROVIDES INVESTOR HOTLINE
ONTARIO, Calif., March 13, 2026 /PRNewswire/ -- Nature's Miracle Holding Inc. ("Nature's Miracle" or the "Company") (OTCQB: NMHI), a leader in controlled environment agriculture, today announced that it is setting up an investor hotline at...
Nature's Miracle Holding Inc. Begins Offering Made-in-USA Grow Lights Through Exclusive Agreement with Megaphoton USA LLC
ONTARIO, Calif., Feb. 17, 2026 /PRNewswire/ -- Nature's Miracle Holding Inc. ("Nature's Miracle," "NMHI," or the "Company"), a provider of equipment and services for the controlled environment agriculture (CEA) industry, today announced it has...
NATURE'S MIRACLE HOLDING INC. PARTICIPATES IN INDOOR AG-CON 2026
ONTARIO, Calif., Feb. 11, 2026 /PRNewswire/ -- Nature's Miracle Holding Inc. ("Nature's Miracle," "NMHI," or the "Company") (OTCQB: NMHI), a provider of equipment and services for the controlled environment agriculture ("CEA") industry, today...
Nature's Miracle Holding Inc. Appoints Dr. Jinlong "Frank" Du as President of Agricultural Business
ONTARIO, Calif., Feb. 4, 2026 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB: NMHI) today announced the appointment of Dr. Jinlong "Frank" Du as President of the Company's Agricultural Business. Dr. Du is a globally recognized entrepreneur and...
Nature's Miracle Holding Inc. Records a One-Time Gain of $6.9 Million From the Debt Settlement and Mutual Release with Megaphoton Inc.
ONTARIO, Calif., Feb. 4, 2026 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB: NMHI) ("Nature's Miracle" or the "Company"), a leader in controlled environment agricultural technology, today announced it has entered into a formal Settlement...
Nature | Two Phase 3 Clinical Results of Mazdutide (GLP-1/GCG Dual Receptor Agonist) in Chinese Adults with Type 2 Diabetes Have Been Back-to-Back Published in Nature
SAN FRANCISCO and SUZHOU, China, Dec. 18, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of...
Nature-Based Solutions Pave the Way for a Climate-Resilient and Biodiverse Hong Kong: New Report from The Nature Conservancy and Civic Exchange
Nature-based solutions (NbS) are critical to Hong Kong's climate resilience and biodiversity strategy, particularly in the Northern Metropolis. A new report by The Nature Conservancy and Civic Exchange outlines a bold roadmap for integrating NbS...
Green Fund to be Launched to Advance Global Decarbonization Efforts
HONG KONG, May 20, 2025 /PRNewswire/ -- A high-quality carbon credit fund, incorporated and managed by a subsidiary of Arta TechFin Corporation Limited ("ARTA TechFin", Stock Code: 0279.HK), has been launched in collaboration with Singapore Treasure...
Nature's Miracle Holding Inc. Announces Up to $20 Million Financing with GHS Investment
ONTARIO, Calif., May 7, 2025 /PRNewswire/ -- Nature's Miracle Holding Inc. (OTCQB:NMHI) ("Nature's Miracle" or the "Company"), a leader in vertical farming technology, today announced that the Company has entered into an equity purchase financing...